Incyte (INCY) Stock Forecast for 2024–2028. Sell or Buy Prediction







Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading

Human error is common in forex trading and often leads to familiar trading issues. These trading mishaps lead to significant novice traders regularly. …

Incyte (INCY) Stock Forecast for 2024–2028. Sell or Buy?

Updated: April 14, 2024 (06:06)

Sector: Healthcare

The share price of Incyte Corp. (INCY) now

Latest session on the 12th of April for
Incyte Corp. is negative
Trading Volume: 1227465
Open: 54.72 /  High: 55.03 /  Low: 53.76
What analysts predict: $75.41
52-week High/Low: $75.74 / $50.27

50/200 Day Moving Average: $58.54 / $59.85

This figure corresponds to the Average Price over the previous 50/200 days. For Incyte stocks, the 50-day moving average is the resistance level today.

For Incyte stocks, the 200-day moving average is the resistance level today.

Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2024, 2025, 2026, 2027, 2028. How much will one Incyte share be worth in 2024 - 2028?

When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock? We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.


Historical and forecast chart of Incyte stock

The chart below shows the historical price of Incyte stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.

Long-term forecasts by years.

Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.

www.incyte.com

Incyte daily forecast for a month

Date Target Pes. Opt. Vol., %
Apr 16 54.71 53.71 55.51 3.36
Apr 17 54.64 54.13 55.74 2.97
Apr 18 53.31 52.80 54.39 3.00
Apr 19 53.55 52.28 54.50 4.24
Apr 20 53.88 53.12 54.65 2.89
Apr 21 53.60 52.80 54.08 2.44
Apr 22 53.81 52.84 54.68 3.48
Apr 23 54.58 54.14 55.58 2.66
Apr 24 55.45 54.35 56.07 3.15
Apr 25 54.64 53.80 55.15 2.50
Apr 26 54.44 53.20 55.01 3.41
Apr 27 55.22 54.23 56.28 3.79
Apr 28 54.96 53.66 55.49 3.41
Apr 29 56.48 55.31 57.68 4.29
Apr 30 55.80 54.54 56.99 4.48
May 01 55.53 55.03 56.00 1.76
May 02 55.80 54.91 56.52 2.93
May 03 55.36 54.05 56.34 4.24
May 04 55.40 54.53 56.28 3.20
May 05 54.45 53.44 55.15 3.21
May 06 54.79 53.95 55.17 2.25
May 07 55.32 54.40 56.05 3.02
May 08 55.30 54.29 56.05 3.24
May 09 56.00 55.43 57.34 3.46
May 10 56.53 56.06 57.32 2.24
May 11 55.81 54.53 56.34 3.32
May 12 55.20 53.96 56.25 4.24
May 13 54.86 54.43 55.63 2.21
May 14 53.39 52.41 54.13 3.27
May 15 53.98 53.35 54.37 1.91

Incyte Daily Price Targets


Incyte Stock Forecast 04-16-2024.

Forecast target price for 04-16-2024: $54.71.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.252%.
Pessimistic target level: 53.71
Optimistic target level: 55.51

Incyte Stock Forecast 04-17-2024.

Forecast target price for 04-17-2024: $54.64.
Negative dynamics for Incyte shares will prevail with possible volatility of 2.882%.
Pessimistic target level: 54.13
Optimistic target level: 55.74

Incyte Stock Forecast 04-18-2024.

Forecast target price for 04-18-2024: $53.31.
Negative dynamics for Incyte shares will prevail with possible volatility of 2.911%.
Pessimistic target level: 52.80
Optimistic target level: 54.39

Incyte Stock Forecast 04-19-2024.

Forecast target price for 04-19-2024: $53.55.
Positive dynamics for Incyte shares will prevail with possible volatility of 4.068%.
Pessimistic target level: 52.28
Optimistic target level: 54.50

Incyte Stock Forecast 04-20-2024.

Forecast target price for 04-20-2024: $53.88.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.810%.
Pessimistic target level: 53.12
Optimistic target level: 54.65

Incyte Stock Forecast 04-21-2024.

Forecast target price for 04-21-2024: $53.60.
Negative dynamics for Incyte shares will prevail with possible volatility of 2.379%.
Pessimistic target level: 52.80
Optimistic target level: 54.08

INCY (INCY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
May. 53.20 51.43 55.45 7.25
Jun. 51.53 49.90 53.89 7.40
Jul. 52.64 51.36 53.97 4.83
Aug. 48.75 47.88 52.22 8.32
Sep. 47.57 45.34 49.28 7.99
Oct. 51.17 49.69 52.69 5.68
Nov. 53.28 49.64 56.35 11.91
Dec. 51.61 48.35 53.18 9.08

Incyte forecast for this year


Incyte Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $53.2016. Pessimistic: $51.43. Optimistic: $55.45


Incyte Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $51.5258. Pessimistic: $49.90. Optimistic: $53.89


Incyte Stock Prediction for Jul 2024

An uptrend is forecast for this month with an optimal target price of $52.6387. Pessimistic: $51.36. Optimistic: $53.97


Incyte Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $48.754. Pessimistic: $47.88. Optimistic: $52.22


Incyte Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $47.5693. Pessimistic: $45.34. Optimistic: $49.28


Incyte Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $51.1655. Pessimistic: $49.69. Optimistic: $52.69


Incyte Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $53.2838. Pessimistic: $49.64. Optimistic: $56.35


Incyte Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $51.6053. Pessimistic: $48.35. Optimistic: $53.18



Incyte (INCY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 49.56 48.45 51.66 6.22
Feb 54.02 52.37 57.67 9.19
Mar 55.14 52.46 58.91 10.95
Apr 57.18 55.84 59.90 6.79
May 55.01 51.55 56.95 9.48
Jun 54.72 52.40 57.77 9.29
Jul 54.27 51.25 55.93 8.38
Aug 53.83 50.98 54.95 7.23
Sep 58.44 55.86 61.49 9.15
Oct 58.02 54.78 60.42 9.33
Nov 60.47 59.11 61.67 4.15
Dec 58.67 55.45 60.36 8.14

Incyte (INCY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 55.61 54.26 58.81 7.74
Feb 53.71 52.07 55.74 6.59
Mar 49.65 46.52 52.02 10.57
Apr 54.12 50.85 56.94 10.69
May 56.99 54.99 59.56 7.67
Jun 59.56 57.63 60.74 5.12
Jul 59.34 56.99 63.35 10.03
Aug 54.16 50.31 57.09 11.87
Sep 53.82 51.83 55.61 6.79
Oct 53.58 50.83 55.80 8.90
Nov 54.16 51.96 55.28 6.00
Dec 53.33 49.68 54.34 8.57

Incyte (INCY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 57.17 54.65 59.84 8.68
Feb 57.53 55.51 61.51 9.76
Mar 56.34 52.69 59.63 11.65
Apr 55.07 52.19 58.09 10.15
May 56.11 52.52 57.62 8.85
Jun 58.63 56.21 61.01 7.87
Jul 61.80 60.13 63.19 4.84
Aug 59.24 57.27 63.24 9.44
Sep 59.78 57.68 62.09 7.10
Oct 57.30 56.22 58.44 3.79
Nov 59.72 58.27 63.16 7.74
Dec 62.20 59.45 66.00 9.92

Incyte (INCY) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 64.49 62.93 66.87 5.90
Feb 62.29 60.10 63.58 5.47
Mar 65.99 64.74 68.30 5.22
Apr 65.16 60.76 67.21 9.60
May 65.80 64.02 68.47 6.49
Jun 63.49 59.21 67.66 12.50
Jul 68.69 64.92 71.97 9.79
Aug 70.05 65.20 75.09 13.18
Sep 68.60 63.97 73.29 12.72
Oct 68.60 66.62 72.55 8.17
Nov 68.54 65.33 72.30 9.64
Dec 66.38 62.20 70.50 11.78

Incyte information and performance

Incyte Address

1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US

Market Capitalization: 12 402 817 000 $

Market capitalization of the Incyte Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INCY shares in the company outstanding by the market price of one share.

EBITDA: 738 524 000 $

EBITDA of Incyte is earnings before interest, income tax and depreciation of assets.

PE Ratio: 20.85

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.712

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.65

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 6.32
Quarterly Revenue Growth YOY: 0.093
Trailing PE: 20.85

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.68

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.377

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.55

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 224526000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.